Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis

Angiogenesis

Volumn 19, Issue 2, 2016, Pages 191-200

  Yang, J P ^a   Liao, Y D ^b   Mai, D M ^a   Xie, P ^a   Qiang, Y Y ^a   Zheng, L S ^a   Wang, M Y ^a   Mei, Y ^a   Meng, D F ^a   Xu, L ^a   Cao, L ^a   Yang, Q ^a   Yang, X X ^c   Wang, W B ^c   Peng, L X ^a   Huang, B J ^a   Qian, C N ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Meta analysis; Solid tumor; Survival; Vasculogenic mimicry

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CLINICAL FEATURE; DISEASE ASSOCIATION; DISTANT METASTASIS; ETHNICITY; HUMAN; LYMPH NODE METASTASIS; NEWCASTLE OTTAWA QUALITY SCORE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TUMOR VASCULARIZATION; VASCULOGENIC MIMICRY; GENETIC HETEROGENEITY; META ANALYSIS; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROGNOSIS; PUBLISHING; SURVIVAL ANALYSIS; VASCULARIZATION;

GENETIC HETEROGENEITY; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PUBLICATION BIAS; SURVIVAL ANALYSIS;

EID: 84959143338     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-016-9500-2     Document Type: Article

References (78)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
2. Stacker SA, Achen MG (2013) The VEGF signaling pathway in cancer: the road ahead. Chin J Cancer 32:297–302
3. Liu J, Huang J, Yao WY, Ben QW, Chen DF et al (2012) The origins of vacularization in tumors. Front Biosci (Landmark Ed) 17:2559–2565
4. Qin L, Bromberg-White JL, Qian CN (2012) Opportunities and challenges in tumor angiogenesis research: back and forth between bench and bed. Adv Cancer Res 113:191–239
5. Qian CN (2013) Hijacking the vasculature in ccRCC–co-option, remodelling and angiogenesis. Nat Rev Urol 10:300–304
6. Qian CN, Tan MH, Yang JP, Cao Y (2016) Revisiting tumor angiogenesis: vessel co-option, vessel remodeling, and cancer cell-derived vasculature formation. Chin J Cancer 35:10
7. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM et al (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739–752
8. Qiao L, Liang N, Zhang J, Xie J, Liu F et al (2015) Advanced research on vasculogenic mimicry in cancer. J Cell Mol Med 19:315–326
9. Chen YS, Chen ZP (2014) Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer 33:74–79
10. Sun B, Zhang S, Zhao X, Zhang W, Hao X (2004) Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int J Oncol 25:1609–1614
11. Zhang S, Li M, Zhang D, Xu S, Wang X et al (2009) Hypoxia influences linearly patterned programmed cell necrosis and tumor blood supply patterns formation in melanoma. Lab Invest 89:575–586
12. Van Beurden A, Schmitz RF, Van Dijk CM, Baeten CIM (2012) Periodic acid Schiff loops and blood lakes associated with metastasis in cutaneous melanoma. Melanoma Res 22:424–429
13. Dunleavey JM, Xiao L, Thompson J, Kim MM, Shields JM et al (2014) Vascular channels formed by subpopulations of PECAM1+ melanoma cells. Nat Commun 5:5200
14. Sun B, Qie S, Zhang S, Sun T, Zhao X et al (2008) Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors. Hum Pathol 39:444–451
15. Li M, Gu Y, Zhang Z, Zhang S, Zhang D et al (2010) Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma. Pathol Oncol Res 16:259–266
16. Song YY, Sun LD, Liu ML, Liu ZL, Chen F et al (2014) STAT3, p-STAT3 and HIF-1alpha are associated with vasculogenic mimicry and impact on survival in gastric adenocarcinoma. Oncol Lett 8:431–437
17. Zhou L, Yu L, Feng ZZ, Gong XM, Cheng ZN et al (2015) Aberrant expression of markers of cancer stem cells in gastric adenocarcinoma and their relationship to vasculogenic mimicry. Asian Pac J Cancer Prev 16:4177–4183
18. Wang LGY, Zhang S, Sun B (2009) Pilot study and clinical prognosis significance of vasculogenic mimicry in leiomyosarcoma. Tianjin Med J 37:161
19. Gao Y, Zhao XL, Gu Q, Wang JY, Zhang SW et al (2009) Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma. Zhonghua Bing Li Xue Za Zhi 38:585–589
20. Yu L, Wu SW, Zhou L, Song WQ (2012) Correlation between bacterial L-form infection, expression of HIF-1alpha/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer. Sheng Li Xue Bao 64:657–665
21. Sun Q, Zou X, Zhang T, Shen J, Yin Y et al (2014) The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer. Gynecol Oncol 132:730–738
22. Sun B, Zhang S, Zhang D, Du J, Guo H et al (2006) Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. Oncol Rep 16:693–698
23. Liu WB, Xu GL, Jia WD, Li JS, Ma JL et al (2011) Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma. Med Oncol 28(Suppl 1):S228–S238
24. Shirakawa K, Wakasugi H, Heike Y, Watanabe I, Yamada S et al (2002) Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer 99:821–828
25. Liu T, Sun B, Zhao X, Li Y, Gu Q et al (2014) OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer. Int J Mol Sci 15:19634–19649
26. Liu SY, Chang LC, Pan LF, Hung YJ, Lee CH et al (2008) Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol 44:277–285
27. Wang W, Lin P, Han C, Cai W, Zhao X et al (2010) Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma. J Exp Clin Cancer Res 29:60
28. Baeten CI, Hillen F, Pauwels P, de Bruine AP, Baeten CG (2009) Prognostic role of vasculogenic mimicry in colorectal cancer. Dis Colon Rectum 52:2028–2035
29. Liu Z, Sun B, Qi L, Li H, Gao J et al (2012) Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition. Cancer Sci 103:813–820
30. Liu XM, Zhang QP, Mu YG, Zhang XH, Sai K et al (2011) Clinical significance of vasculogenic mimicry in human gliomas. J Neurooncol 105:173–179
31. Wang SY, Ke YQ, Lu GH, Song ZH, Yu L et al (2013) Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma. J Neurooncol 112:339–345
32. Cheng L, Huang Z, Zhou W, Wu Q, Donnola S et al (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153:139–152
33. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE et al (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468:829–833
34. Wu S, Yu L, Cheng Z, Song W, Zhou L et al (2012) Expression of maspin in non-small cell lung cancer and its relationship to vasculogenic mimicry. J Huazhong Univ Sci Technol Med Sci 32:346–352
35. Li Y, Sun B, Zhao X, Zhang D, Wang X et al (2015) Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer. Exp Mol Pathol 98:136–144
36. Wang X, Wang L, Gu Y, Zhang S, Zhao X et al (2009) Vasculogenic mimicry in testicular germ cell malignant tumor and its significance for prognosis. Chin J Clin Oncol 36:78–82
37. Sun W, Shen ZY, Zhang H, Fan YZ, Zhang WZ et al (2012) Overexpression of HIF-1alpha in primary gallbladder carcinoma and its relation to vasculogenic mimicry and unfavourable prognosis. Oncol Rep 27:1990–2002
38. Liu R, Yang K, Meng C, Zhang Z, Xu Y (2012) Vasculogenic mimicry is a marker of poor prognosis in prostate cancer. Cancer Biol Ther 13:527–533
39. Chai DM, Bao ZQ, Hu JG, Ma L, Feng ZZ et al (2013) Vasculogenic mimicry and aberrant expression of HIF-lalpha/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma. J Huazhong Univ Sci Technol Med Sci 33:385–391
40. Zhang Y, Sun B, Zhao X, Liu Z, Wang X et al (2013) Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. J Surg Oncol 108:414–419
41. Ren K, Yao N, Wang G, Tian L, Ma J et al (2014) Vasculogenic mimicry: a new prognostic sign of human osteosarcoma. Hum Pathol 45:2120–2129
42. Zhang X, Liu C, Luo L, Cai X (2013) Vasculogenic mimicry in tongue squamous cell carcinoma. Nan Fang Yi Ke Da Xue Xue Bao 33:593–597
43. Hillen F, Baeten CI, van de Winkel A, Creytens D, van der Schaft DW et al (2008) Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma. Cancer Immunol Immunother 57:97–106
44. Jang TL, Bekelman JE, Liu Y, Bach PB, Basch EM et al (2010) Physician visits prior to treatment for clinically localized prostate cancer. Arch Int Med 170:440–450
45. Knobloch K, Yoon U, Vogt PM (2011) Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias. J Craniomaxillofac Surg 39:91–92
46. Panic N, Leoncini E, de Belvis G, Ricciardi W, Boccia S (2013) Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses. PLoS ONE 8:e83138
47. Sun B, Zhang S, Ni C (2005) The clinical significance study of vasculogenetic mimicry in 337 cases of bi-directional differential malignant tumors. Chin J Clin Oncol 32:64–67
48. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12
49. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
50. Whitehead A, Whitehead J (1991) A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 10:1665–1677
51. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
52. Galbraith RF (1988) A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 7:889–894
53. Patsopoulos NA, Evangelou E, Ioannidis JP (2008) Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation. Int J Epidemiol 37:1148–1157
54. Mullen B, Muellerleile P, Bryant B (2001) Cumulative meta-analysis: a consideration of indicators of sufficiency and stability. Pers Soc Psychol Bull 27:1450–1462
55. Soeken KL, Sripusanapan A (2003) Assessing publication bias in meta-analysis. Nurs Res 52:57–60
56. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
57. Qi H, Sun B, Zhao X, Du J, Gu Q et al (2014) Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Calpha in epithelial ovarian cancer. Oncol Rep 32:771–779
58. Cao Y (2009) Angiogenesis in malignancy. Semin Cancer Biol 19:277–278
59. Silvan U, Diez-Torre A, Bonilla Z, Moreno P, Diaz-Nunez M et al (2015) Vasculogenesis and angiogenesis in nonseminomatous testicular germ cell tumors. Urol Oncol 33(268):e217–e268
60. Brown JM (2014) Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. Br J Radiol 87:20130686
61. Qing YL, Sha TH, Ji FY, Qin HK, Jun CX et al (2009) Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancer. Int J Gynecol Obstet 107:S242
62. Pezzella F, Harris AL (2014) When cancer co-opts the vasculature. N Engl J Med 370:2146–2147
63. Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM et al (2012) Tumor cell vasculogenic mimicry: from controversy to therapeutic promise. Am J Pathol 181:1115–1125
64. Cao Z, Bao M, Miele L, Sarkar FH, Wang Z et al (2013) Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. Eur J Cancer 49:3914–3923
65. Wagenblast E, Soto M, Gutierrez-Angel S, Hartl CA, Gable AL et al (2015) A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis. Nature 520:358–362
66. Yao XH, Ping YF, Bian XW (2011) Contribution of cancer stem cells to tumor vasculogenic mimicry. Protein Cell 2:266–272
67. Vartanian A, Gatsina G, Grigorieva I, Solomko E, Dombrovsky V et al (2013) The involvement of Notch signaling in melanoma vasculogenic mimicry. Clin Exp Med 13:201–209
68. McAllister JC, Zhan Q, Weishaupt C, Hsu MY, Murphy GF (2010) The embryonic morphogen, Nodal, is associated with channel-like structures in human malignant melanoma xenografts. J Cutan Pathol 37(Suppl 1):19–25
69. Tang N, Shi H, Zhang J (2013) HIF-1alpha induces expression of VE-cadherin and modulates vasculogenic mimicry in ESCC cells. J Gastroenterol Hepatol 28:863
70. Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor REB et al (2006) VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther 5:228–233
71. Wang W, Lin P, Sun B, Zhang S, Cai W et al (2014) Epithelial-mesenchymal transition regulated by EphA2 contributes to vasculogenic mimicry formation of head and neck squamous cell carcinoma. Biomed Res Int 2014:803914
72. Margaryan NV, Strizzi L, Abbott DE, Seftor EA, Rao MS et al (2009) EphA2 as a promoter of melanoma tumorigenicity. Cancer Biol Ther 8:275–284
73. Lu XS, Sun W, Ge CY, Zhang WZ, Fan YZ (2013) Contribution of the PI3 K/MMPs/Ln-5gamma2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. Int J Oncol 42:2103–2115
74. Shi R, Jin HL, Zhang HJ (2011) Effect of RNA interference targeting for HIF-1(alpha) on vasculogenic mimicry in esophageal squamous cell carcinoma. Gastroenterology 140:S827
75. Comito G, Calvani M, Giannoni E, Bianchini F, Calorini L et al (2011) HIF-1alpha stabilization by mitochondrial ROS promotes Met-dependent invasive growth and vasculogenic mimicry in melanoma cells. Free Radic Biol Med 51:893–904
76. Du J, Sun B, Zhao X, Gu Q, Dong X et al (2014) Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma. Gynecol Oncol 133:575–583
77. Osinsky S, Zavelevich M, Vaupel P (2009) Tumor hypoxia and malignant progression. Exp Oncol 31:80–86
78. Sun B, Zhang D, Zhang S, Zhang W, Guo H et al (2007) Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett 249:188–197